A complete 1,3-galactosyltransferase gene is present in the human genome and partially transcribed
Open Access
- 1 December 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 12 (12), 785-792
- https://doi.org/10.1093/glycob/cwf087
Abstract
The synthesis of Galα1-3Gal-terminated oligosaccharides (α-Gal) epitopes has been interrupted during the course of evolution, starting with Old World primates. Partial sequences similar to the α1,3-galactosyltransferase (α1,3GalT) gene, which governs the synthesis of α-Gal epitopes, have been detected in the human genome and were found to correspond to pseudogenes. We completed the sequence of the human α1,3GalT pseudogene present on chromosome 9 and found it to be organized like the murine α1,3GalT gene. In human cell lines and several normal and tumor tissues we detected truncated transcripts corresponding to this pseudogene. Considering these mRNAs, translation of an open reading frame containing the first four translated exons but missing the two catalytic exons could predict a truncated α1,3GalT polypeptide that should be enzymatically inactive. We show that transcription of human α1,3GalT is prematurely terminated at the level of a strong transcriptional stop signal in the middle of intron VII. We were able to reproduce this effect in vitro by subcloning the implicated DNA region upstream from a reporter cDNA. The premature transcriptional arrest of human α1,3-GalT gene leads to an ectopic splicing event and to the connection of a short intronic sequence downstream from translated exons. Finally, we show that these truncated transcripts are overexpressed in cell lines with modifications of O-glycans.Keywords
This publication has 22 references indexed in Scilit:
- Getting into the GolgiTrends in Cell Biology, 1998
- Cloning and Expression of cDNA for a Human Gal(β1‐3)GalNAc α2,3‐Sialyltransferase from the CEM T‐Cell LineEuropean Journal of Biochemistry, 1997
- Standardized nomenclature for Alu repeatsJournal of Molecular Evolution, 1996
- The Human 180-kDa Receptor for Secretory Phospholipases A2Journal of Biological Chemistry, 1995
- Defining the minimal size of catalytically active primate α1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzymeGlycobiology, 1994
- Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.Proceedings of the National Academy of Sciences, 1991
- Possible Role of Human Natural Anti-Gal Antibodies in the Natural Antitumor Defense SystemJNCI Journal of the National Cancer Institute, 1989
- Biosynthesis of terminal Gal alpha 1—-3Gal beta 1—-4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1—-3-galactosyltransferase from calf thymus.Published by Elsevier ,1985
- Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.The Journal of Experimental Medicine, 1985
- A unique natural human IgG antibody with anti-alpha-galactosyl specificity.The Journal of Experimental Medicine, 1984